Cannabis and Endometriosis Pain

Plain-language summary

Endometriosis is a chronic inflammatory condition where tissue similar to the uterine lining grows outside the uterus, causing pelvic pain, painful periods, painful sex, bowel and bladder symptoms, fatigue, and sometimes infertility. It affects roughly 10% of women and people assigned female at birth of reproductive age ^[1] Strong evidence.

Standard treatments — NSAIDs, hormonal suppression, and laparoscopic excision surgery — help many people but fail or cause intolerable side effects in others ^[1][2]. That gap is why a lot of patients have turned to cannabis. Online surveys from Australia, Canada, the US, and the UK consistently find that 10–25% of endometriosis patients have tried cannabis for symptom relief, and most who try it report at least some benefit, especially for pain and sleep ^[3][4] Weak / limited.

The catch: those are self-reports, not controlled trials. There is no published randomized, placebo-controlled trial of cannabis or any single cannabinoid in endometriosis. So we're working with biological plausibility plus patient experience, not proof.

This is not medical advice. If you have endometriosis or suspect you do, work with a clinician — ideally one with endometriosis expertise — before using cannabis as part of your management.

What probably works

Honestly, nothing about cannabis in endometriosis meets a "probably works" bar if we're being strict. There are no RCTs. The strongest claim the evidence supports is:

• Subjective short-term pain and sleep relief in some patients. Across multiple independent surveys, the most consistently reported benefits are reduction in pelvic pain severity and improved sleep, with effect sizes patients describe as meaningful ^[3][4][5] Weak / limited. This is consistent with the broader chronic-pain literature, where cannabis shows small-to-modest analgesic effects in controlled trials of other conditions ^[6] Weak / limited.

That is the entire "probably" column. Anyone selling you more certainty than that is overselling.

What might work

• Reducing use of other medications. In Armour et al.'s Australian survey, a majority of cannabis-using endometriosis patients reported cutting back on opioids, benzodiazepines, or other analgesics ^[3] Weak / limited. Self-report only; no objective verification.
• Helping with associated symptoms — nausea, anxiety, gut cramping, and dyspareunia were rated as improved by substantial minorities in survey work ^[3][4] Weak / limited.
• CBD-dominant preparations for pain and inflammation. Biologically plausible: the endocannabinoid system is expressed in endometrial tissue, and CB1/CB2 signaling modulates pain and inflammation ^[7][8][evidence:strong for the biology, evidence:none for clinical endometriosis outcomes]. Animal models of endometriosis show cannabinoid agonists reduce lesion growth and hyperalgesia ^[9] Weak / limited. Whether that translates to humans is unknown.
• Vaginal/rectal suppositories are popular in patient communities for localized pelvic pain. There is essentially no controlled data on absorption or efficacy Anecdote.

What doesn't work or has weak evidence

• Cannabis as a cure or disease-modifying therapy. There is no human evidence that cannabis shrinks endometriotic lesions or alters disease progression No data. Animal data is preliminary ^[9].
• "Indica for cramps, sativa for energy" guidance. The indica/sativa dichotomy doesn't reliably predict chemical profile or effects ^[10] Disputed. See Indica vs Sativa.
• Specific terpene claims (e.g. "beta-caryophyllene at X% relieves pelvic pain"). Mechanistically interesting, clinically unproven in endometriosis No data.
• High-THC flower as a long-term strategy. Daily high-THC use carries tolerance, dependence, and hyperalgesia risks that can worsen pain conditions over months to years ^[11][evidence:weak in endometriosis specifically, stronger in general chronic pain literature].

What we don't know

A lot. Specifically:

• Optimal cannabinoid (THC, CBD, ratio), dose, and route for endometriosis pain.
• Whether cannabis affects fertility in people with endometriosis who want to conceive. General reproductive data suggests THC may impair ovulation and embryo implantation in animal models, and human data is concerning but limited ^[12] Weak / limited.
• Whether cannabis interacts meaningfully with hormonal suppressive therapy (GnRH analogs, progestins, combined hormonal contraceptives). No clinical interaction studies exist.
• Long-term outcomes — pain trajectory, surgery rates, opioid use — in cannabis users vs non-users.
• Whether any of the encouraging animal lesion-suppression findings replicate in humans.

Comparison with standard treatments

Standard treatments have actual trial evidence behind them; cannabis does not. That doesn't make cannabis useless — it makes it adjunctive at best, not a substitute.

• NSAIDs (ibuprofen, naproxen): first-line for menstrual pain. Modest evidence for endometriosis-specific pain but widely used ^[1][evidence:strong for dysmenorrhea generally, evidence:weak in endometriosis specifically].
• Combined hormonal contraceptives and progestins: suppress cyclic pain in many patients; well-studied ^[1] Strong evidence.
• GnRH agonists/antagonists (e.g. elagolix): effective for moderate-to-severe pain, significant side effects ^[2] Strong evidence.
• Laparoscopic excision surgery: the only intervention shown to remove disease and improve pain in RCTs, though recurrence is common ^[1] Strong evidence.
• Pelvic floor physical therapy: underused, evidence growing for the muscular/neuropathic component of endo pain [evidence:weak-to-moderate].
• Cannabis: zero RCTs in endometriosis; positive patient-reported outcomes in surveys Weak / limited.

A reasonable framing: cannabis is in roughly the same evidentiary tier as TENS units or acupuncture for endometriosis — plausibly helpful for symptoms in some people, not a replacement for medical or surgical management.

Risks and practical considerations

• Dependence and tolerance. Roughly 1 in 10 adult cannabis users develop Cannabis Use Disorder; risk is higher with daily high-THC use ^[11] Strong evidence.
• Cannabinoid hyperemesis syndrome. Heavy chronic users can develop cyclic vomiting that mimics or worsens endo-related GI symptoms ^[13] Strong evidence.
• Pregnancy and fertility. Cannabis is not recommended during pregnancy or while trying to conceive. THC crosses the placenta and is associated with low birth weight and developmental concerns ^[12][14] Strong evidence.
• Drug interactions. CBD inhibits CYP enzymes and can raise levels of some medications ^[15] Strong evidence. Relevant if you take SSRIs, anticoagulants, or anti-epileptics.
• Diagnostic delay. The most dangerous risk: using cannabis to cope with worsening pelvic pain instead of getting evaluated. Endometriosis already has an average diagnostic delay of 7+ years ^[1]. Don't add to it.
• Cost and legality vary enormously by jurisdiction.

Again: this article is not medical advice. It's a snapshot of what the evidence does and doesn't show. Decisions about your body and your treatment belong between you and a clinician you trust.

Sources

How this page was made

Related

• Cannabis and Chronic Pain — What the evidence actually says about cannabis for long-term pain, separated from the mark...
• Cannabis Use Disorder — A real DSM-5 diagnosis affecting roughly 1 in 5 regular users, with modest but growing evi...